1. Screening Libraries
  2. Wnt/Hedgehog/Notch Compound Library

Wnt/Hedgehog/Notch Compound Library

Cat. No.: HY-L020
Library Contents: XLSX PDF

A unique collection of 91 small molecule inhibitors with biological activity used for Wnt/Hedgehog/Notch pathway research and screening.

Wnt/Hedgehog/Notch Compound Library
Size (Pre-dissolved DMSO or Solid) Price Stock
30 μL/well (10 mM solution) Get quote In-stock
50 μL/well (10 mM solution) Get quote In-stock
100 μL/well (10 mM solution) Get quote In-stock
250 μL/well (10 mM solution) Get quote In-stock

Please contact us at

[email protected]

Top Publications Citing Use of Products
  • Description

  • Product Details

  • Composition

  • Contents

  • Documentation

Description
& Advantages

•   A unique collection of 91 small molecule inhibitors with biological activity used for Wnt/Hedgehog/Notch pathway research and screening.

•   Targets include Notch, Gli, GSK-3, Hedgehog, Porcupine, sFRP-1, Smo, Wnt, β-catenin, etc.

•   A useful tool for the research of Wnt/Hedgehog/Notch-related regulation and diseases.

•   Bioactivity and safety confirmed by preclinical research and clinical trials. Some inhibitors have been approved by FDA.

•   Structurally diverse, medicinally active, and cell permeable.

•   More detailed compound information with structure, IC50, and brief introduction.

•   NMR and HPLC validated to ensure high purity and quality.

•   All compounds are in stock and continuously updated.

Product Details
Formulation:
A collection of 91 Wnt/Hedgehog/Notch signaling related compounds supplied as pre-dissolved DMSO solutions or Solid
Container:
96 Well Format Sample Storage Tube With Screw Cap and Optional 2D Barcode
Storage:
-80°C
Shipping:
Blue ice
Composition

Wnt/Hedgehog/Notch Compound Library

Source: MedChem Express

Contents of Wnt/Hedgehog/Notch Compound Library

Plate layout: HY-L020-1

1 2 3 4 5 6 7 8 9 10 11 12
a Empty MK-4101 Semagacestat TA-01 SRI-011381 (hydrochloride) Ciliobrevin A NCB-0846 SKL2001 KYA1797K PNU-74654 LF3 Empty
b Empty CHIR-99021 CHIR-99021 (monohydrochloride) KY1220 D4476 iCRT3 Vismodegib 1-(4-Methoxybenzyl)-3-(5-nitrothiazol-2-yl)urea GSK 3 Inhibitor IX TWS119 IQ 1 Empty
c Empty TDZD-8 WAY-262611 RO4929097 SB 216763 IWR-1 IM-12 Kenpaullone Cardiogenol C (hydrochloride) Bikinin Hexachlorophene Empty
d Empty CCT251545 IC261 SIS3 CHIR-98014 LY2940680 GANT 58 JK184 YO-01027 BMS-833923 KY02111 Empty
e Empty GANT 61 Emodin TBB ICG-001 Tideglusib Purmorphamine XAV-939 HhAntag SB 415286 TTP 22 Empty
f Empty PF-670462 DMAT Salinomycin Wnt-C59 LH846 FH535 AZD2858 IWP L6 FLI-06 Kartogenin Empty
g Empty LY2090314 PF-04449913 LDE225 (Diphosphate) LDE225 iCRT 14 WIKI4 LGK974 Berberine (chloride hydrate) RU-SKI 43 (hydrochloride) ETC-159 Empty
h Empty JW74 Indirubin-3'-monoxime BML-284 Triptonide LY-411575 BMS-708163 CX-4945 CX-4945 (sodium salt) Pyrvinium pamoate Pamidronic acid Empty

Plate layout: HY-L020-2

1 2 3 4 5 6 7 8 9 10 11 12
a Empty Verteporfin Pirfenidone Halcinonide Nefopam (hydrochloride) Tangeretin Oxymatrine Wogonin Asiaticoside Jervine Halofuginone Empty
b Empty Gigantol Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
c Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
d Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
e Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
f Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
g Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
h Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
Documentation

Inquiry Online

Your information is safe with us. * Required Fields.

Product name

 

Salutation

Applicant name *

 

Email address *

Phone number *

 

Organization name *

Country or Region *

 

Requested quantity *

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Wnt/Hedgehog/Notch Compound Library
Cat. No.:
HY-L020
Quantity:

Request SDF File

Please enter your email address. We will send your requested SDF file to you as soon as possible.